InvestorsHub Logo
Followers 0
Posts 36
Boards Moderated 1
Alias Born 06/30/2017

Re: rage675 post# 17608

Sunday, 07/30/2017 4:32:42 PM

Sunday, July 30, 2017 4:32:42 PM

Post# of 50157
Important distinction: IHP/PHP

If I am understanding your point correctly; I regret to inform you that you are likely incorrect...

Sources:

Dr. Pingpank and investigators at the
National Cancer Institute originally conducted trials to
Evaluate the use of IHP for these patients. IHP had
significantly positive results, but subsequent treatments
were not possible due to extensive scar tissue in the
operative field upon recurrence of disease.
As the adjunct principal investigator for the Phase
III trial, Dr. Pingpank worked with the manufacturer,
Delcath Systems Inc., to design the PHP system…

IHP was a no-go since it was not repeatable due to scar tissue formation…

http://www.upmccancercenter.com/-/media/cancercenter/for-healthcare-professionals/documents/cancer_insights_fall10.ashx?la=en
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DCTH News